» Articles » PMID: 9895397

Efficacy of Superovulation and Intrauterine Insemination in the Treatment of Infertility. National Cooperative Reproductive Medicine Network

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1999 Jan 23
PMID 9895397
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Induction of superovulation with gonadotropins and intrauterine insemination are frequently used to treat infertility. We conducted a large, randomized, controlled clinical trial of these treatments.

Methods: We studied 932 couples in which the woman had no identifiable infertility factor and the man had motile sperm. The couples were randomly assigned to receive intracervical insemination, intrauterine insemination, superovulation and intracervical insemination, or superovulation and intrauterine insemination. Treatment continued for four cycles unless pregnancy was achieved.

Results: The 231 couples in the group treated with superovulation and intrauterine insemination had a higher rate of pregnancy (33 percent) than the 234 couples in the intrauterine-insemination group (18 percent), the 234 couples in the group treated with superovulation and intracervical insemination (19 percent), or the 233 couples in the intracervical-insemination group (10 percent). Stratified, discrete-time Cox proportional-hazards analysis showed that the couples in the group treated with superovulation and intrauterine insemination were 3.2 times as likely to become pregnant as those in the intracervical-insemination group (95 percent confidence interval, 2.0 to 5.3) and 1.7 times as likely as those in the intrauterine-insemination group (95 percent confidence interval, 1.2 to 2.6). The couples in the intrauterine-insemination group and in the group treated with superovulation and intracervical insemination were nearly twice as likely to conceive as those in the intracervical-insemination group.

Conclusions: Among infertile couples, treatment with induction of superovulation and intrauterine insemination is three times as likely to result in pregnancy as is intracervical insemination and twice as likely to result in pregnancy as is treatment with either superovulation and intracervical insemination or intrauterine insemination alone.

Citing Articles

Investigation of the Effect of Hafnium Chloride on Sperm Viability and Motility in Normospermic Cases: An In Vitro Study.

Ozden Z, Oz Bagci F, Cicek G, Aktan T, Duman S Cureus. 2024; 16(6):e62084.

PMID: 38989327 PMC: 11236213. DOI: 10.7759/cureus.62084.


Optimizing intrauterine insemination: A systematic review and meta-analysis of the effectiveness and safety of clinical treatment add-ons.

Chronopoulou E, Gaetano-Gil A, Shaikh S, Raperport C, Al Wattar B, Ruiz-Calvo G Acta Obstet Gynecol Scand. 2024; 103(10):1919-1932.

PMID: 38961556 PMC: 11426219. DOI: 10.1111/aogs.14858.


The relationship between duration of infertility and clinical outcomes of intrauterine insemination for younger women: a retrospective clinical study.

Huang C, Shi Q, Xing J, Yan Y, Shen X, Shan H BMC Pregnancy Childbirth. 2024; 24(1):199.

PMID: 38486148 PMC: 10938817. DOI: 10.1186/s12884-024-06398-y.


In vitro fertilisation for unexplained subfertility.

Sunkara S, Kamath M, Pandian Z, Gibreel A, Bhattacharya S Cochrane Database Syst Rev. 2023; 9:CD003357.

PMID: 37753821 PMC: 10523437. DOI: 10.1002/14651858.CD003357.pub5.


Optimizing pregnancy outcomes in intrauterine insemination cycles by stratifying pre-wash total motile count and patient-specific factors: a patient counseling tool.

Gordon C, Hammer K, James K, Lanes A, Vagios S, Starosta A J Assist Reprod Genet. 2022; 39(12):2811-2818.

PMID: 36342575 PMC: 9790824. DOI: 10.1007/s10815-022-02636-4.